MLP Health (MPARK)
Stocks
Hold
The speaker examines that the current price is high for this healthcare company and lower levels should be awaited for buying.
FİNANS VE BORSA
FİNANS VE BORSA
Loading...
Loading...
Coverage, strength, recency, conviction and momentum.
No analyses found yet.
Newest calls at the top.
The speaker examines that the current price is high for this healthcare company and lower levels should be awaited for buying.
The speaker examines the digital transformation project signed by the company with AstraZeneca and its AI-supported healthcare goals.
Analysis is not available.
Analysis is not available.
Analysis is not available.
The speaker examines that the current price is high for this healthcare company and lower levels should be awaited for buying.
The speaker examines the digital transformation project signed by the company with AstraZeneca and its AI-supported healthcare goals.
Analysis is not available.
Analysis is not available.
Analysis is not available.